Researchers have developed a vaccine that can fight dust-mite allergies by naturally switching the body's immune response.
The vaccine developed by the researchers at the University of Iowa contains a booster that alters the body's inflammatory response to dust-mite allergens.
Aliasger Salem, professor in pharmaceutical sciences at the UI said that what was new about this is they had developed a vaccine against dust-mite allergens that had not been used before.
Peter Thorne, public health professor at the UI said that their research explored a novel approach to treating mite allergy in which specially-encapsulated miniscule particles were administered with sequences of bacterial DNA that directed the immune system to suppress allergic immune responses.
The study is published in the AAPS (American Association of Pharmaceutical Scientists) Journal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
